Get the Stockscreener App
2.90
7.05%
-0.22
Pre-market:
3.01
0.11
+3.79%
Absci Corp stock is traded at $2.90, with a volume of 2.97M.
It is down -7.05% in the last 24 hours and down -42.00% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$3.12
Open:
$3.14
24h Volume:
2.97M
Relative Volume:
0.58
Market Cap:
$333.08M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-3.1183
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
-6.45%
1M Performance:
-42.00%
6M Performance:
-25.64%
1Y Performance:
-40.57%
1-Day Range:
$2.90
$3.18
1-Week Range:
$2.865
$3.26
52-Week Range:
$2.45
$6.72
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.90 | 333.08M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Absci (ABSI) Projected to Post Earnings on Tuesday - Defense World
Rhumbline Advisers Grows Stake in Absci Co. (NASDAQ:ABSI) - Defense World
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Small-Cap Biotech Absci Draws Heavy Attention On $20M AMD Investment Pledge, Retail's Bullish Despite Pre-Market Dip - MSN
Absci Co. (NASDAQ:ABSI) Receives $8.57 Consensus Target Price from Analysts - MarketBeat
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on - EIN News
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
When and Where to Catch Absci's Next Major Investor Presentation - StockTitan
How Absci's Latest Employee Stock Grant Impacts Investor Outlook - StockTitan
Top 5 AI & Digital Biotech Companies (March 2025) - Securities.io
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
Why Absci Corporation (ABSI) is Skyrocketing So Far in 2025 - Insider Monkey
Absci Co. (NASDAQ:ABSI) Receives Consensus Rating of “Buy” from Analysts - Defense World
Absci (NASDAQ:ABSI) Stock Price Down 11.3%What's Next? - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 11.3%Here's Why - MarketBeat
Absci Co. (NASDAQ:ABSI) Stake Boosted by ARK Investment Management LLC - MarketBeat
Lowe’s Financial Results Beat On Top And Bottom Lines - Baystreet.ca
Absci (NASDAQ:ABSI) Shares Gap UpTime to Buy? - MarketBeat
Is Absci Corp. (ABSI) the Best Nasdaq Stock Under $5 to Buy? - MSN
Absci Co. (NASDAQ:ABSI) Short Interest Down 10.8% in January - MarketBeat
Absci to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
AI Drug Discovery Pioneer Absci Takes Center Stage at Major Healthcare ConferenceKey Innovations Unveiled - StockTitan
Absci (NASDAQ:ABSI) Stock Price Up 6.8%What's Next? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Needham initiates Absci shares with Buy rating on strategy - MSN
Absci (NASDAQ:ABSI) Shares Up 6.8%Still a Buy? - MarketBeat
Absci (NASDAQ:ABSI) Trading Down 4.8%What's Next? - MarketBeat
SG Americas Securities LLC Acquires Shares of 42,222 Absci Co. (NASDAQ:ABSI) - Defense World
Vancouver biotech plans clinical trial of AI-developed drug - The Business Journals
10 Best Nasdaq Stocks Under $5 to Buy - Insider Monkey
Absci Corp (ABSI) Stock: A Year of Highs and Lows - The InvestChronicle
Investors Purchase Large Volume of Call Options on Absci (NASDAQ:ABSI) - Defense World
Analysts Set Absci Co. (NASDAQ:ABSI) Price Target at $8.57 - MarketBeat
FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape - Canada NewsWire
An Analysis of Absci Corp (ABSI)’s Potential Price Growth - Knox Daily
Examining ABSI’s book value per share for the latest quarter - US Post News
Let’s Talk About Wall Street’s Projection For Absci Corp (NASDAQ: ABSI). - Marketing Sentinel
Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise - STAT
Absci (NASDAQ:ABSI) Shares Up 5.8%Time to Buy? - MarketBeat
ABSI Shares Experience Surge in Value - Knox Daily
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Absci Corp Stock (ABSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):